What does it mean to compare two stocks using a business-model lens?

A business-model comparison examines how each company earns revenue, how its products and services create value, and how resilient its model is to external shocks. For Verisk and Teradyne, this means contrasting a data analytics platform with subscription elements versus a diversified hardware and automation portfolio affected by technology cycles. The goal is to understand operating leverage and growth drivers, not to predict stock moves.

How can growth drivers differ between a data analytics company and an automation/testing firm?

Growth drivers for Verisk stem from data-enabled services, AI-enabled analytics, and international expansion under a recurring revenue model. Teradyne relies on demand cycles in semiconductors and electronics testing, product innovation, and diversification into automation. These differing drivers affect revenue visibility, margins, and sensitivity to industry cycles.

What is the role of profitability and margins in this comparison?

Profitability and margins indicate how effectively a company converts revenue into profits. Verisk shows strong margins with a subscription model, while Teradyne benefits from recurring revenue and a diversified portfolio. In contrast, both face cycle-related risks—Verisk in acquisitions, Teradyne in semiconductor downturns—affecting margin stability.

How should one interpret price multiples like P/E or price-to-sales in this page’s context?

Higher multiples may reflect stronger growth or unique market positions, but can also indicate higher expectations. Verisk’s elevated valuation is weighed against its analytics leadership and margins, while Teradyne’s multiple reflects exposure to tech cycles. Compare multiples relative to sector norms and assess whether growth justifies premium.

Why are revenue growth and earnings guidance important in this comparison?

Revenue growth tracks top-line momentum, while earnings guidance reflects management’s expectations and visibility. Verisk’ s mixed recent results and a cautious FY25 outlook contrast with Teradyne’s cyclical exposure but resilient margins. Understanding guidance helps gauge risk, quality of earnings, and future cash flow potential.

What does diversification mean for these two companies’ risk profiles?

Verisk diversifies through international expansion and new segments, potentially lowering idiosyncratic risk but adding integration risk from acquisitions. Teradyne diversifies via a broad product portfolio but faces higher cyclicality and competitive pressure. Diversification can dampen or shift risk depending on execution and market conditions.

How do external market cycles impact these two stocks differently?

Verisk’s growth is less tied to cyclical swings and more to adoption of analytics platforms and insurance tech trends. Teradyne is more exposed to semiconductor and electronics cycles, with earnings and demand swinging with capital expenditure and tech demand, influencing timing of revenue and margins.

What role do acquisitions play in each company’s market context?

Acquisitions can accelerate Verisk’s product suite and international reach but raise integration risk and execution challenges. For Teradyne, acquisitions may bolster capabilities and diversification yet increase leverage and require successful capital allocation. Market interpretation weighs potential growth against integration risk.

How should a beginner use this page when evaluating investments?

A beginner should compare how each company earns money, growth trajectories, and risk factors. Look at margins, revenue visibility, and cycle exposure. Use the provided context to assess whether each company’s market position supports long-term resilience, while noting the absence of any buy/sell recommendations.

Where can one find a concise takeaway from this comparison and a clear educational note?

The page offers a balanced view of two different business models: Verisk (data analytics with subscription revenue) and Teradyne (testing hardware with cyclical demand). It presents risks, growth drivers, and market considerations to aid understanding, emphasising that this is educational content, not investment advice.

What is the educational disclaimer included in this page?

This page is intended to educate readers about how to compare two stocks and understand potential drivers and risks. It does not constitute financial advice or a recommendation to buy, hold, or sell any security, and readers should consult a licensed advisor for personalised guidance.

Live Report · Updated April 27, 2026

Verisk vs Teradyne

Movado sells Swiss-made watches and licensed fashion timepieces through department stores and its own boutiques, relying on brand positioning and gifting occasions to drive a relatively modest but profitable revenue base, while Waldencast is a beauty and wellness platform that acquired Obagi Medical and Milk Makeup to build a portfolio of prestige skincare and cosmetics brands. Both companies sell premium consumer products where brand equity is the primary economic asset and wholesale channel relationships determine reach. Movado vs Waldencast shows how an established watch brand with consistent cash generation compares to a newer beauty platform still integrating acquisitions and building its direct-to-consumer engine.

Movado sells Swiss-made watches and licensed fashion timepieces through department stores and its own boutiques, relying on brand positioning and gifting occasions to drive a relatively modest but pro...

Comparison Snapshot

Key Financial Metrics

VRSK

Metric

TER

$24.65B

Market Cap

$47.96B

33.16%

Potential Profit

-40.54%

Buy

Analyst Rating

Buy

Why It's Moving

Analysts Eye +18% VRSK Upside on Robust Earnings Momentum and Sector Tailwinds

Verisk crushed consensus EPS estimates in each of the last four quarters, underscoring its reliable execution and deepening client reliance on its data analytics for risk management.
Analysts project 4.4% EPS growth to $6.93 for fiscal 2025, fueled by rising demand for Verisk's AI-driven solutions amid volatile insurance markets.
Broader sector strength in insurtech is amplifying optimism, as peers report surging adoption of predictive analytics to tackle climate and cyber risks.

Sentiment:

🐃Bullish

TER Stock Warning: Why Analysts See -33% Downside Risk

Stock dropped 1.29% to $90.15 on July 25, 2025, after falling 8.59% from a pivot top on July 10, signaling ongoing weakness until a new bottom forms.
Short- and long-term moving averages both issue sell signals, with resistance looming at $92.82 and $90.39, curbing any near-term rebound hopes.
MACD shows a sell signal over three months, amplifying negative momentum in a volatile market averaging 2.90% daily swings last week.

Sentiment:

🐻Bearish

Analysts Eye +18% VRSK Upside on Robust Earnings Momentum and Sector Tailwinds

Verisk crushed consensus EPS estimates in each of the last four quarters, underscoring its reliable execution and deepening client reliance on its data analytics for risk management.
Analysts project 4.4% EPS growth to $6.93 for fiscal 2025, fueled by rising demand for Verisk's AI-driven solutions amid volatile insurance markets.
Broader sector strength in insurtech is amplifying optimism, as peers report surging adoption of predictive analytics to tackle climate and cyber risks.

Sentiment:

🐃Bullish

TER Stock Warning: Why Analysts See -33% Downside Risk

Stock dropped 1.29% to $90.15 on July 25, 2025, after falling 8.59% from a pivot top on July 10, signaling ongoing weakness until a new bottom forms.
Short- and long-term moving averages both issue sell signals, with resistance looming at $92.82 and $90.39, curbing any near-term rebound hopes.
MACD shows a sell signal over three months, amplifying negative momentum in a volatile market averaging 2.90% daily swings last week.

Sentiment:

🐻Bearish

Investment Analysis

Verisk

VRSK

Pros

Verisk maintains a leading position in insurance data analytics with advanced AI and cloud-based solutions.
The company demonstrates consistent revenue growth, supported by a robust subscription model and strong profit margins.
Verisk is expanding internationally and into new segments through strategic acquisitions and product innovation.

Considerations

Recent financial results have been mixed, with net income declining and FY25 sales guidance cut below estimates.
Valuation metrics are elevated compared to sector averages, with a high P/E and price-to-sales ratio.
The business faces execution risks from integrating recent acquisitions and evolving from a utility to a technology network.

Teradyne

TER

Pros

Teradyne benefits from strong demand in semiconductor and electronics testing, driven by global technology trends.
The company has a diversified product portfolio and a solid track record of innovation in automation solutions.
Teradyne maintains healthy margins and a resilient business model, supported by recurring revenue streams.

Considerations

Revenue and earnings are sensitive to semiconductor industry cycles, exposing Teradyne to cyclical downturns.
The company faces intense competition from larger rivals and emerging players in the automation and testing space.
Recent acquisitions have increased leverage, raising concerns about integration risks and return on capital.

Related Market Insights

Digital Guardians: Why Child Safety Regulation Could Spark the Next Tech Investment Wave

Explore the Digital Guardians Neme. Regulatory pressure on tech platforms sparks demand for online child safety solutions. Invest in companies leading content moderation & identity verification.